| Literature DB >> 33398113 |
Nicolas Baillet1,2, Stéphanie Reynard1,2, Emeline Perthame3, Jimmy Hortion1,2, Alexandra Journeaux1,2, Mathieu Mateo1,2, Xavier Carnec1,2, Justine Schaeffer1,2, Caroline Picard1,2, Laura Barrot4, Stéphane Barron4, Audrey Vallve4, Aurélie Duthey4, Frédéric Jacquot4, Cathy Boehringer4, Grégory Jouvion5, Natalia Pietrosemoli3, Rachel Legendre3, Marie-Agnès Dillies3, Richard Allan6, Catherine Legras-Lachuer6, Caroline Carbonnelle4, Hervé Raoul4, Sylvain Baize7,8.
Abstract
Lassa virus (LASV) is endemic in West Africa and induces a viral hemorrhagic fever (VHF) with up to 30% lethality among clinical cases. The mechanisms involved in control of Lassa fever or, in contrast, the ensuing catastrophic illness and death are poorly understood. We used the cynomolgus monkey model to reproduce the human disease with asymptomatic to mild or fatal disease. After initial replication at the inoculation site, LASV reached the secondary lymphoid organs. LASV did not spread further in nonfatal disease and was rapidly controlled by balanced innate and T-cell responses. Systemic viral dissemination occurred during severe disease. Massive replication, a cytokine/chemokine storm, defective T-cell responses, and multiorgan failure were observed. Clinical, biological, immunological, and transcriptomic parameters resembled those observed during septic-shock syndrome, suggesting that similar pathogenesis is induced during Lassa fever. The outcome appears to be determined early, as differentially expressed genes in PBMCs were associated with fatal and non-fatal Lassa fever outcome very early after infection. These results provide a full characterization and important insights into Lassa fever pathogenesis and could help to develop early diagnostic tools.Entities:
Year: 2021 PMID: 33398113 PMCID: PMC7782745 DOI: 10.1038/s42003-020-01543-7
Source DB: PubMed Journal: Commun Biol ISSN: 2399-3642